Use of digoxin and risk of death or readmission for heart failure and sinus rhythm: A nationwide propensity score matched study.

[1]  B. Uretsky,et al.  Randomized Study Assessing the Effect of Digoxin Withdrawal i n Patients With Mild to Moderate Chronic Congestive Heart Failure : Results of the PROVED Trial , 2016 .

[2]  G. Guyatt,et al.  Digitalis for treatment of heart failure in patients in sinus rhythm. , 2014, The Cochrane database of systematic reviews.

[3]  M. Lisby,et al.  Identifying high-risk medication: a systematic literature review , 2014, European Journal of Clinical Pharmacology.

[4]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[5]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[6]  Juerg Schwitter,et al.  ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 , 2010, European journal of heart failure.

[7]  K. Dickstein,et al.  Aliskiren, ALTITUDE, and the implications for ATMOSPHERE , 2012, European journal of heart failure.

[8]  Timothy L Lash,et al.  The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients , 2011, BMC medical research methodology.

[9]  S. Rasmussen,et al.  The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  B. Pitt,et al.  Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial. , 2009, The American journal of cardiology.

[11]  L. Køber,et al.  Accuracy of a heart failure diagnosis in administrative registers , 2008, European journal of heart failure.

[12]  G. Fonarow,et al.  Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.

[13]  A. Hoes,et al.  Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.

[14]  Eliot Corday,et al.  Overview of Acutely Decompensated Congestive Heart Failure (ADHF): A Report from the ADHERE Registry , 2005, Heart Failure Reviews.

[15]  Harlan M Krumholz,et al.  Association of serum digoxin concentration and outcomes in patients with heart failure. , 2003, JAMA.

[16]  T. Nickelsen,et al.  [Data validity and coverage in the Danish National Health Registry. A literature review]. , 2001, Ugeskrift for laeger.

[17]  H. Sørensen,et al.  The Danish prescription registries. , 1997, Danish medical bulletin.

[18]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[19]  A. Skene,et al.  Treatment of severe heart failure: quantity or quality of life? A trial of enoximone. Enoximone Investigators. , 1994, British heart journal.

[20]  M. Gheorghiade,et al.  WITHDRAWAL OF DIGOXIN FROM PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS , 2010 .

[21]  D. DeMets,et al.  Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. , 1991, The New England journal of medicine.

[22]  R. Mayou,et al.  Exercise capacity and quality of life in the treatment of heart failure , 1990, Clinical pharmacology and therapeutics.

[23]  R. Schlant,et al.  A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. , 1989, The New England journal of medicine.

[24]  G. Guyatt,et al.  A controlled trial of digoxin in congestive heart failure. , 1988, The American journal of cardiology.

[25]  M. Wilén,et al.  Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. , 1988, JAMA.

[26]  M. Gheorghiade,et al.  Effects of discontinuing maintenance digoxin therapy in patients with ischemic heart disease and congestive heart failure in sinus rhythm. , 1983, The American journal of cardiology.

[27]  R. A. Johnson,et al.  Heart failure in outpatients: a randomized trial of digoxin versus placebo. , 1982, The New England journal of medicine.

[28]  S. Hull,et al.  DISCONTINUATION OF MAINTENANCE DIGOXIN THERAPY IN GENERAL PRACTICE , 1977, The Lancet.

[29]  R. Dobbs,et al.  Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients. , 1977, British medical journal.

[30]  J. Kelly,et al.  The Efficacy of Digitalis Withdrawal in an Institutional Aged Population , 1974, Journal of the American Geriatrics Society.

[31]  J. Dall.  Maintenance Digoxin in Elderly Patients , 1970, British medical journal.